CASP3 and adrenal cortex carcinoma: In DFI (Figure 4A), in contrast to the CASP3-related good prognosis in OV (p = 0.013), CASP3 overexpression was associated with poor prognosis in ACC (p = 0.008), KIRP (p = 0.048), LUAD (p = 0.005), and THCA (p < 0.001).